{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:48:11Z","timestamp":1789267691443,"version":"build-2803163510"},"reference-count":67,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T00:00:00Z","timestamp":1640131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010653","name":"Masaryk University","doi-asserted-by":"publisher","award":["MUNI\/A\/1689\/2020"],"award-info":[{"award-number":["MUNI\/A\/1689\/2020"]}],"id":[{"id":"10.13039\/501100010653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010653","name":"Masaryk University","doi-asserted-by":"publisher","award":["MUNI\/A\/1390\/2020"],"award-info":[{"award-number":["MUNI\/A\/1390\/2020"]}],"id":[{"id":"10.13039\/501100010653","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Masaryk Memorial Cancer Institute","award":["00209805"],"award-info":[{"award-number":["00209805"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Copper is an endogenous metal ion that has been studied to prepare a new antitumoral agent with less side-effects. Copper is involved as a cofactor in several enzymes, in ROS production, in the promotion of tumor progression, metastasis, and angiogenesis, and has been found at high levels in serum and tissues of several types of human cancers. Under these circumstances, two strategies are commonly followed in the development of novel anticancer Copper-based drugs: the sequestration of free Copper ions and the synthesis of Copper complexes that trigger cell death. The latter strategy has been followed in the last 40 years and many reviews have covered the anticancer properties of a broad spectrum of Copper complexes, showing that the activity of these compounds is often multi factored. In this work, we would like to focus on the anticancer properties of mixed Cu(II) complexes bearing substituted or unsubstituted 1,10-phenanthroline based ligands and different classes of inorganic and organic auxiliary ligands. For each metal complex, information regarding the tested cell lines and the mechanistic studies will be reported and discussed. The exerted action mechanisms were presented according to the auxiliary ligand\/s, the metallic centers, and the increasing complexity of the compound structures.<\/jats:p>","DOI":"10.3390\/molecules27010049","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T02:01:19Z","timestamp":1640224879000},"page":"49","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Copper(II) Phenanthroline-Based Complexes as Potential AntiCancer Drugs: A Walkthrough on the Mechanisms of Action"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8913-6251","authenticated-orcid":false,"given":"Sebastiano","family":"Masuri","sequence":"first","affiliation":[{"name":"Department of Chemical and Geological Sciences, University of Cagliari, 09042 Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Va\u0148hara","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic"},{"name":"International Clinical Research Center, St. Anne\u2019s University Hospital, 65691 Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9819-8996","authenticated-orcid":false,"given":"Maria Grazia","family":"Cabiddu","sequence":"additional","affiliation":[{"name":"Department of Chemical and Geological Sciences, University of Cagliari, 09042 Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luk\u00e1\u0161","family":"Mor\u00e1\u0148","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic"},{"name":"Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 65653 Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Havel","sequence":"additional","affiliation":[{"name":"International Clinical Research Center, St. Anne\u2019s University Hospital, 65691 Brno, Czech Republic"},{"name":"Department of Chemistry, Faculty of Science, Masaryk University, 62500 Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Cadoni","sequence":"additional","affiliation":[{"name":"Department of Chemical and Geological Sciences, University of Cagliari, 09042 Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Pivetta","sequence":"additional","affiliation":[{"name":"Department of Chemical and Geological Sciences, University of Cagliari, 09042 Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: Molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00280-016-2976-z","article-title":"Platinum-based drugs: Past, present and future","volume":"77","author":"Dilruba","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.ccr.2009.01.028","article-title":"Mechanistic insight into the cellular uptake and processing of cisplatin 30 years after its approval by FDA","volume":"253","author":"Arnesano","year":"2009","journal-title":"Coord. Chem. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1039\/C8DT00838H","article-title":"The side effects of platinum-based chemotherapy drugs: A review for chemists","volume":"47","author":"Oun","year":"2018","journal-title":"Dalt. Trans."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jab.2015.03.003","article-title":"Coordination compounds in cancer: Past, present and perspectives","volume":"13","author":"Trudu","year":"2015","journal-title":"J. Appl. Biomed."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1753-4887.2009.00250.x","article-title":"New developments in the regulation of intestinal copper absorptionn","volume":"67","author":"Klomp","year":"2009","journal-title":"Nutr. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jtemb.2016.02.006","article-title":"Dietary copper and human health: Current evidence and unresolved issues","volume":"35","author":"Bost","year":"2016","journal-title":"J. Trace Elem. Med. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11243-012-9583-6","article-title":"Redox active metal-induced oxidative stress in biological systems","volume":"37","author":"Jomova","year":"2012","journal-title":"Transit. Met. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jtemb.2019.06.008","article-title":"Copper homeostasis as target of both consolidated and innovative strategies of anti-tumor therapy","volume":"55","author":"Barile","year":"2019","journal-title":"J. Trace Elem. Med. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.2741\/1424","article-title":"Copper storage diseases: Menkes, Wilson\u2019s, and Cancer","volume":"9","author":"Daniel","year":"2004","journal-title":"Front. Biosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000226722","article-title":"Serum and Tissue Trace Metal Levels in Lung Cancer","volume":"46","author":"Arroyo","year":"1989","journal-title":"Oncology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1088\/0031-9155\/47\/13\/310","article-title":"Concentrations of Fe, Cu and Zn in breast tissue: A synchrotron XRF study","volume":"47","author":"Geraki","year":"2002","journal-title":"Phys. Med. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1039\/C5MT00149H","article-title":"Targeting copper in cancer therapy: \u201cCopper That Cancer\u201d","volume":"7","author":"Denoyer","year":"2015","journal-title":"Metallomics"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"12269","DOI":"10.1016\/S0021-9258(19)86305-6","article-title":"Oxygen-dependent cleavage of DNA by the 1,10-phenanthroline cuprous complex. Inhibition of Escherichia coli DNA polymerase I","volume":"254","author":"Sigman","year":"1979","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ccr.2010.09.002","article-title":"Metal complexes for DNA-mediated charge transport","volume":"255","author":"Barton","year":"2011","journal-title":"Coord. Chem. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1021\/acs.biochem.1c00302","article-title":"Rhodium Complexes Targeting DNA Mismatches as a Basis for New Therapeutics in Cancers Deficient in Mismatch Repair","volume":"60","author":"Nano","year":"2021","journal-title":"Biochemistry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/187152009787313837","article-title":"Copper Complexes as Anticancer Agents","volume":"9","author":"Marzano","year":"2009","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/cr400135x","article-title":"Advances in copper complexes as anticancer agents","volume":"114","author":"Santini","year":"2014","journal-title":"Chem. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Molinaro, C., Martoriati, A., Pelinski, L., and Cailliau, K. (2020). Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II. Cancers, 12.","DOI":"10.3390\/cancers12102863"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.drudis.2021.01.015","article-title":"Biochemical pathways of copper complexes: Progress over the past 5 years","volume":"26","author":"Zehra","year":"2021","journal-title":"Drug Discov. Today"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Krasnovskaya, O., Naumov, A., Guk, D., Gorelkin, P., Erofeev, A., Beloglazkina, E., and Majouga, A. (2020). Copper coordination compounds as biologically active agents. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21113965"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1039\/C6MT00105J","article-title":"Copper and conquer: Copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics","volume":"8","author":"Park","year":"2016","journal-title":"Metallomics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jinorgbio.2012.04.017","article-title":"Mixed-1,10-phenanthroline\u2013Cu(II) complexes: Synthesis, cytotoxic activity versus hematological and solid tumor cells and complex formation equilibria with glutathione","volume":"114","author":"Pivetta","year":"2012","journal-title":"J. Inorg. Biochem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jinorgbio.2014.08.011","article-title":"Novel copper(II) complexes as new promising antitumour agents. A crystal structure of [Cu(1,10-phenanthroline-5,6-dione)2 (OH2)(OClO3)](ClO4)","volume":"141","author":"Pivetta","year":"2014","journal-title":"J. Inorg. Biochem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1039\/C8RA09652J","article-title":"Cisplatin, glutathione and the third wheel: Acopper-(1,10-phenanthroline) complex modulates cisplatin-GSH interactions from antagonism to synergism in cancer cells resistant to cisplatin","volume":"9","author":"Vascellari","year":"2019","journal-title":"RSC Adv."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1039\/c9mt00055k","article-title":"Mixed copper(II)\u2013phenanthroline complexes induce cell death of ovarian cancer cells by evoking the unfolded protein response","volume":"11","author":"Pivetta","year":"2019","journal-title":"Metallomics"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1039\/C8DT00794B","article-title":"Hypotoxic copper complexes with potent anti-metastatic and anti-angiogenic activities against cancer cells","volume":"47","author":"Shi","year":"2018","journal-title":"Dalt. Trans."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1039\/d0mt00006j","article-title":"The first copper(II) complex with 1,10-phenanthroline and salubrinal with interesting biochemical properties","volume":"12","author":"Masuri","year":"2020","journal-title":"Metallomics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/chem.202001996","article-title":"Polypyridyl-Based Copper Phenanthrene Complexes: Combining Stability with Enhanced DNA Recognition","volume":"27","author":"Fantoni","year":"2021","journal-title":"Chem.-A Eur. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"8599","DOI":"10.1021\/jm401465m","article-title":"Regulating bioactivity of Cu2+ Bis-1,10-phenanthroline artificial metallonucleases with sterically functionalized pendant carboxylates","volume":"56","author":"Prisecaru","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2007.04.064","article-title":"Apoptotic cell death: A possible key event in mediating the in vitro anti-proliferative effect of a novel copper(II) complex, [Cu(4-Mecdoa)(phen)2] (phen = phenanthroline, 4-Mecdoa = 4-methylcoumarin-6,7-dioxactetate), in human malignant cancer cells","volume":"569","author":"Thati","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1039\/C0DT01607A","article-title":"Bis-phenanthroline copper(II) phthalate complexes are potent in vitro antitumour agents with \u201cself-activating\u201d metallo-nuclease and DNA binding properties","volume":"40","author":"Kellett","year":"2011","journal-title":"Dalt. Trans."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3892\/ijo.2016.3542","article-title":"Anticancer activity and computational modeling of ternary copper (II) complexes with 3-indolecarboxylic acid and 1,10-phenanthroline","volume":"49","author":"Zhang","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1002\/ange.201510443","article-title":"Breast Cancer Stem Cell Potent Copper(II)-Non-Steroidal Anti-Inflammatory Drug Complexes","volume":"128","author":"Boodram","year":"2016","journal-title":"Angew. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"119778","DOI":"10.1016\/j.ica.2020.119778","article-title":"Water-soluble copper(II) complexes with 4,5-dichloro-isothiazole-3-carboxylic acid and heterocyclic N-donor ligands: Synthesis, crystal structures, cytotoxicity, and DNA binding study","volume":"510","author":"Eremina","year":"2020","journal-title":"Inorg. Chim. Acta"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1039\/C9MT00165D","article-title":"Structure and anticancer activities of four Cu(II) complexes bearing tropolone","volume":"11","author":"Mo","year":"2019","journal-title":"Metallomics"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00775-019-01749-z","article-title":"Mixed ligand complexes of Co(II), Ni(II) and Cu(II) with quercetin and diimine ligands: Synthesis, characterization, anti-cancer and anti-oxidant activity","volume":"25","author":"Erkisa","year":"2020","journal-title":"J. Biol. Inorg. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6906","DOI":"10.1039\/c2cc31023f","article-title":"Potent oxidative DNA cleavage by the di-copper cytotoxin: [Cu2(\u03bc-terephthalate)(1,10-phen)4]2+","volume":"48","author":"Prisecaru","year":"2012","journal-title":"Chem. Commun."},{"key":"ref_40","unstructured":"Ruiz Azuara, L. (1991). Process to Obtain New Mixed Copper Aminoacidate Complexes from Phenanthrolines and Their Alkyl Derivatives to be Used as Anticancerigenic Agents. (European Patent Application EP0434445A2)."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.tox.2009.12.010","article-title":"Casiope\u00edna IIgly-induced oxidative stress and mitochondrial dysfunction in human lung cancer A549 and H157 cells","volume":"268","author":"Kachadourian","year":"2010","journal-title":"Toxicology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0006-2952(03)00212-0","article-title":"Toxic effects of copper-based antineoplastic drugs (Casiopeinas\u00ae) on mitochondrial functions","volume":"65","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cbi.2006.12.002","article-title":"Mixed chelate copper complex, Casiopeina IIgly\u00ae, binds and degrades nucleic acids: A mechanism of cytotoxicity","volume":"165","author":"Plant","year":"2007","journal-title":"Chem. Biol. Interact."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.tiv.2007.11.011","article-title":"Casiope\u00edna IIgly induced cytotoxicity to HeLa cells depletes the levels of reduced glutathione and is prevented by dimethyl sulfoxide","volume":"22","year":"2008","journal-title":"Toxicol. Vitr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.tox.2003.08.009","article-title":"Hematotoxicity response in rats by the novel copper-based anticancer agent: Casiopeina II","volume":"194","author":"Howarth","year":"2003","journal-title":"Toxicology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"742859","DOI":"10.3389\/fmolb.2021.742859","article-title":"1H -NMR Metabolomics Study of the Effect of Cisplatin and Casiopeina-II Gly on MDA-MB-231 Breast Tumor Cells","volume":"8","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10534-016-9983-8","article-title":"The mitochondrial apoptotic pathway is induced by Cu(II) antineoplastic compounds (Casiope\u00ednas\u00ae) in SK-N-SH neuroblastoma cells after short exposure times","volume":"30","year":"2017","journal-title":"BioMetals"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Ruiz-Azuara, L., Bastian, G., Bravo-G\u00f3mez, M.E., Ca\u00f1as, R.C., Flores-Alamo, M., Fuentes, I., Mejia, C., Garc\u00eda-Ramos, J.C., and Serrano, A. Abstract CT408: Phase I study of one mixed chelates copper(II) compound, Casiope\u00edna CasIIIia with antitumor activity and its mechanism of action. Proceedings of the Clinical Trials.","DOI":"10.1158\/1538-7445.AM2014-CT408"},{"key":"ref_49","unstructured":"(2021, August 13). 2nd March 2017; New Cancer Drug Called Casiope\u00ednas Tested at Phase I Clinical Trials, Source: Information Agency CONACYT. Available online: http:\/\/www.salud.carlosslim.org\/english2\/new-cancer-drug-called-casiopeinas-tested-at-phase-i-clinical-trials\/."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jinorgbio.2017.07.025","article-title":"Evaluation of the binding of four anti-tumor Casiope\u00ednas\u00ae to human serum albumin","volume":"175","author":"Correia","year":"2017","journal-title":"J. Inorg. Biochem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"110933","DOI":"10.1016\/j.jinorgbio.2019.110933","article-title":"Ternary copper(II) complex of 5-hydroxytryptophan and 1,10-phenanthroline with several pharmacological properties and an adequate safety profile","volume":"204","author":"Naso","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1080\/00958972.2019.1680834","article-title":"ROS-mediated cell death induced by mixed ligand copper(II) complexes of l-proline and diimine: Effect of co-ligand","volume":"72","author":"Karpagam","year":"2019","journal-title":"J. Coord. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s10534-012-9572-4","article-title":"Biological and cytoselective anticancer properties of copper(II)-polypyridyl complexes modulated by auxiliary methylated glycine ligand","volume":"25","author":"Seng","year":"2012","journal-title":"BioMetals"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1021\/acsmedchemlett.9b00284","article-title":"Novel Copper Complexes That Inhibit the Proteasome and Trigger Apoptosis in Triple-Negative Breast Cancer Cells","volume":"10","author":"Li","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15761\/CRR.1000161","article-title":"Copper-diimine coordination compounds as potential new tools in the treatment of cancer","volume":"2","author":"Alvarez","year":"2018","journal-title":"Cancer Reports Rev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jinorgbio.2014.06.007","article-title":"Synthesis, structural characterization and cytotoxic activity of ternary copper(II)-dipeptide-phenanthroline complexes. A step towards the development of new copper compounds for the treatment of cancer","volume":"139","author":"Iglesias","year":"2014","journal-title":"J. Inorg. Biochem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"9888","DOI":"10.1039\/D0DT01527J","article-title":"Copper(II) L\/D-valine-(1,10-phen) complexes target human telomeric G-quadruplex motifs and promote site-specific DNA cleavage and cellular cytotoxicity","volume":"49","author":"Arjmand","year":"2020","journal-title":"Dalt. Trans."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bbagen.2016.10.014","article-title":"Synthesis, biological characterization and evaluation of molecular mechanisms of novel copper complexes as anticancer agents","volume":"1861","author":"Acilan","year":"2017","journal-title":"Biochim. Biophys. Acta-Gen. Subj."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"8452","DOI":"10.1021\/ic201028e","article-title":"Ferrocene-conjugated l-tryptophan copper(II) complexes of phenanthroline bases showing DNA photocleavage activity and cytotoxicity","volume":"50","author":"Goswami","year":"2011","journal-title":"Inorg. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1248\/cpb.58.1003","article-title":"Synthesis, Characterization, Cytotoxic Activities, and DNA-Binding Studies of Ternary Copper(II) Complexes with New Coumarin Derivatives","volume":"58","author":"Jia","year":"2010","journal-title":"Chem. Pharm. Bull."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/ejic.202100125","article-title":"A Cancer Stem Cell Potent Copper(II) Complex with a S, N, S-Schiff base Ligand and Bathophenanthroline","volume":"2021","author":"Kaur","year":"2021","journal-title":"Eur. J. Inorg. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Periasamy, V.S., Riyasdeen, A., Rajendiran, V., Palaniandavar, M., Krishnamurthy, H., Alshatwi, A.A., and Akbarsha, M.A. (2020). Induction of Redox-Mediated Cell Death in ER-Positive and ER-Negative Breast Cancer Cells by a Copper(II)-Phenolate Complex: An In Vitro and In Silico Study. Molecules, 25.","DOI":"10.3390\/molecules25194504"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ejmech.2014.02.049","article-title":"Copper complexes with phosphonium containing hydrazone ligand: Topoisomerase inhibition and cytotoxicity study","volume":"76","author":"Chew","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ica.2018.09.044","article-title":"Synthesis, DNA binding and in vitro cytotoxicity studies of a mononuclear copper(II) complex containing N2S(thiolate)Cu core and 1,10-phenanthroline as a coligand","volume":"484","author":"Kumar","year":"2019","journal-title":"Inorg. Chim. Acta"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1039\/c0md00266f","article-title":"Water-soluble bis(1,10-phenanthroline) octanedioate Cu2+ and Mn2+ complexes with unprecedented nano and picomolar in vitro cytotoxicity: Promising leads for chemotherapeutic drug development","volume":"2","author":"Kellett","year":"2011","journal-title":"Med. Chem. Comm."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00775-019-01651-8","article-title":"Efficient hydrolytic cleavage of DNA and antiproliferative effect on human cancer cells by two dinuclear Cu(II) complexes containing a carbohydrazone ligand and 1,10-phenanthroline as a coligand","volume":"24","author":"Parsekar","year":"2019","journal-title":"J. Biol. Inorg. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1039\/D0DT01742F","article-title":"A simultaneously GSH-depleted bimetallic Cu(II) complex for enhanced chemodynamic cancer therapy","volume":"49","author":"Cao","year":"2020","journal-title":"Dalt. Trans."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/1\/49\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:51:18Z","timestamp":1760169078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/1\/49"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,22]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["molecules27010049"],"URL":"https:\/\/doi.org\/10.3390\/molecules27010049","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,22]]}}}